510(k) K032693
K032693 is an FDA 510(k) premarket notification submitted by Integra Lifesciences Corp. for the device "DURAGEN PLUS DURAL GRAFT MATRIX". The FDA issued a decision of Substantially Equivalent on Sep 30, 2003. The device falls under product code GXQ (Dura Substitute), a Class II device regulated under 21 CFR 882.5910. Integra Lifesciences Corp. has 28 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Sep 30, 2003
- Date Received
- Sep 2, 2003
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Dura Substitute
- Device Class
- Class II
- Regulation Number
- 882.5910
- Review Panel
- NE
- Submission Type
- 510(k)